Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Alto Neuroscience (ANRO) Interest Expenses (2023 - 2026)

Alto Neuroscience has reported Interest Expenses over the past 4 years, most recently at $545000.0 for Q1 2026.

  • Quarterly results put Interest Expenses at $545000.0 for Q1 2026, down 8.86% from a year ago — trailing twelve months through Mar 2026 was $2.4 million (up 48.49% YoY), and the annual figure for FY2025 was $2.5 million, up 79.56%.
  • Interest Expenses reached $545000.0 in Q1 2026 per ANRO's latest filing, down from $575000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $650000.0 in Q3 2025 and bottomed at $324000.0 in Q1 2023.
  • Median Interest Expenses over the past 4 years was $356000.0 (2023), compared with a mean of $443000.0.
  • The largest annual shift saw Interest Expenses skyrocketed 86.25% in 2025 before it fell 8.86% in 2026.
  • Over 4 years, Interest Expenses stood at $356000.0 in 2023, then decreased by 6.46% to $333000.0 in 2024, then surged by 72.67% to $575000.0 in 2025, then decreased by 5.22% to $545000.0 in 2026.
  • Business Quant data shows Interest Expenses for ANRO at $545000.0 in Q1 2026, $575000.0 in Q4 2025, and $650000.0 in Q3 2025.